Stochasticity in cancer immunotherapy stems from rare but functionally critical Spark T cells

Key Points

• Cancer immunotherapy may face challenges due to stochasticity, which is variability in cell function.
• Key findings suggest that rare Spark T cells play a crucial role in treatment effectiveness, influencing outcomes.
• Analysis across various patient profiles reveals significant differences in the functionality of T cells.
• This highlights the need for personalized approaches in immunotherapy, acknowledging the impact of rare cell types.